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Clinical, histological and i,nmunohistochemical follow-up in
diffuse and focal lupus glomerulonephritis (GN). J. Ph. Mery,
L. Morel-Maroger, J. Boelaert and 0. Richet, Service de Néphro-
logie, Hôpital Tenon, Paris, France. Fifty-five renal biopsies,
with immunofluorescence in 40, were performed in 24 patients
with lupus nephritis. The initial biopsy showed a diffuse GN in
18, a focal GN in 6. The average time between first and last
biopsies was 31 months. Of the 18 patients with diffuse GN,
9 showed a parallel clinical, histological and immunohistochemi-
cal improvement (glomerular lesions regressed to minimal changes
in one, became focal in five, remained diffuse but less severe in
three, active lesions disappeared in all; parietal IgO deposits
diminished in all of the six patients in whom serial immunofluo-
rescence was obtained (their pattern changing from a coarse to
either a finely granular or a mesangial one). Nine patients showed
no improvement. The only significant difference between the two
groups was the prednisone dosage: 8/9 of the improved patients
had received at least I mg/kg/day during three months or 0.6
mg/kg/day during five months, while only 2/9 of the "non-
improved" ones had received this dose. Of the six patients with
focal GN, four showed no subsequent histological change; none
of these had received such a high prednisone dosage. A diffuse
GN, with simultaneous clinical and immunohistochemical
aggravation, developed in two; however, one of these had been
given 0.8 mg/kg/day of prednisone during six months. In both
cases, IgG was then found in greater amount, having changed
from a purely mesangial to a coarse parietal deposition. These
data demonstrate the variable histological evolution of lupus GN
and the efficiency of a prolonged high dose prednisone treatment
in most cases.
Value of virus-like inclusions for the diagnosis of S. L. E. in
glomerular disease. G. Lagrue, J. Bariety, P. Druet, Melle Richer
and Melle G. Hirbec. Hôpital Henri-Mondor, Créteil et Hôpital
Broussais (INSERM-CNRS, Association Claude Bernard), Paris,
France. Renal involvement can be the first sign of S. L. E. with
L. E. cells and antinuclear factor (ANF). Virus-like inclusions
within the glomerular endothelium cells have been observed
with high prevalence in S. L. E., but their diagnostic value is not
clear: identical structures have been described in other forms of
glomerular diseases and in other systemic diseases. In these
other diseases however their prevalence is lower and their demon-
stration much more tedious. We have observed two patients with
glomerular disease (one with extramembranous deposits, one
other with membrano-proliferative glomerulonephritis) without
clinical and biological signs of S. L. E. but with virus-like inclu-
sions in glomeruli. A complete remission followed the admini-
stration of alkylating agents (leukeran). Two years later, signs
of acute S. L. E. occured with ANF and positive L. F. cells
without signs of renal involvement. Since the initial glomerular
lesions are compatible with lupoid renal involvement, it is suges-
ted that unique pathological process (S. L. F.) is responsible of
the two clinical pictures in these patients. Despite uncertainty
as to their pathogenetic significance, easy demonstration of
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virus-like inclusions within endothelial cells in patients with
glomerular disease would be of practical value in the diagnosis
of S. L. E.
An experimental approach to the pat hogenesis of septemic
lupus erythematosus. P. H. Lambert, D. Creighton, R. Joodman,
A. Bankhurst and P. A. Miescher, W. H. 0, Research Unit,
Geneva Blood Lentes, Hôpital Cantonal, Geneva, Switzerland. The
study of the pathogenesis of systemic lupus erythematosus has
been developed in the hybrid mice NZB/W, which manifest
autoimmune type serological conditions coupled with renal
lesions similar to these observed in the pathology of the human
disease. The pathogenesis of the nephritis is probably linked to a
viral infection. In the first phase, which is not particularly severe,
complexes of leukemic virus antigens and the corresponding anti-
bodies become localized in the kidneys. In the second phase,
anti-DNA antibodies appear in the circulation, and become
localized in the initial lesions. They are responsible for the rapid
and severe development of the nephritis. Antigen-antibody
complexes, particularly DNA-anti-DNA, have been detected in
the serum as a result of new techniques which are easily appli-
cable to human serum. The etiology of the lupus-like experimen-
tal model would seem to lie in a genetic predisposition to stimula-
tion by DNA, manifesting itself at the level of the B lymphocyte,
coupled with the antigenic stimulation resulting from a natural
infection of leukemia-type virus. There are certain factors which
modify the immunological response with respect to DNA, thus
favouring the development of the disease. This is the case with
certain drugs, for example procainamide, and with endocrine
factors.
Cellular immunity in systemic lupus erythematosus (S. L. E).
J. Dormont, A. Sobel, P. Galanaud, J. Boelaert, J. Ph. Mery and
G. Richet, Hôpital Necker and Hôpital Tenon, Paris, France.
Evaluation of cellular immunity was made in 48 cases of definite
SLE, in 12 cases of "probable" or "possible" SLE, in 14 cases
of glomerulonephritis without evidence of SLE and in 25 normal
controls. Inhibition of leukocyte migration was obtained with
native or heat-denaturated DNA in 42% of definite SLE and
58% of probable or possible SLE but also in 42% of cases of
glomerulonephritis not due to SLE, whereas normal controls
were negative. Thus an abnormal response has been demonstrated
in SLE but is not specific of this condition. Lymphocyte culture
with phytohemagglutinin (PHA) or DNA was made in 11 cases
of SLE. No stimulation was obtained with DNA. Lymphocyte
stimulation with PHA was definitely suboptimal, as measured
with 3H-thymidine incorporation. The failure of PHA to stimulate
SLE lymphocytes as compared to normal lymphocytes was more
conspicuous when the mitogen was diluted 1:20 or 1:50 (P<
0.001) than when it was used undiluted (P<0.05). These latter
findings are in favor of a deficit of thymus-mediated cellular
immunity in SLE. Whether the abnormal response to DNA in
the leukocyte migration test is indicative of a combined delayed
hypersensitivity to DNA remains to be established.
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